Several factors converge to make this moment politically explosive:

• New FDA leadership transition: With Commissioner Makary's departure and the pending confirmation of Dr. Heidi Overton, Schumer is positioning the Senate to influence the new commissioner's enforcement priorities from day one. See our coverage of Overton's confirmation and what it means for vaping.
• Accelerated authorization push: The Trump administration's plan to speed up PMTA reviews (reported by WSJ on September 23) has raised concerns that easier legal market entry could be paired with stronger enforcement — or could accidentally legitimize products that shouldn't be on the market. See our analysis of the accelerated authorization push.
• Youth usage data: While youth vaping rates have declined from peak levels, the ubiquity of cheap, flavored disposables from Chinese manufacturers keeps teen access high. Schumer's letter specifically references products with cartoon packaging and youth-appealing names.
• Pre-election positioning: With November elections approaching, being seen as tough on illicit vapes and protecting children is politically safe ground for both parties.